Application | Comment | Organism |
---|---|---|
diagnostics | GCNT2 is a regulator of epithelial-mesenchymal transition (EMT) and a candidate prognostic indicator of outcome in esophageal squamous cell carcinoma (ESCC) patients | Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | Q8N0V5 | - |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
esophageal squamous cell carcinoma cell | expression of GCNT2 is significantly higher in tumour tissues than in paratumour tissues, tissue microarray analysis | Homo sapiens | - |
Synonyms | Comment | Organism |
---|---|---|
GCNT2 | - |
Homo sapiens |
I-branching N-acetylglucosaminyltransferase | - |
Homo sapiens |
General Information | Comment | Organism |
---|---|---|
malfunction | manipulation of I-branching N-acetylglucosaminyltransferase (GCNT2) expression in esophageal squamous cell carcinoma cells has no effect on cell proliferation. Overexpression of GCNT2 promotes the migration and invasion, and this effect is associated with increased expression of N-cadherin and vimentin and decreased expression of E-cadherin in KYSE30 and EC9706 cells. Knockdown of GCNT2 decreased the expression of N-cadherin and vimentin, increases the expression of E-cadherin, and inhibits the migration and invasion in KYSE150 and EC109 cells | Homo sapiens |
physiological function | overall survival is significantly lower in esophageal squamous cell carcinoma patients with high GCNT2 expression than those with low GCNT2 expression | Homo sapiens |